Forecasting future prevalence and gender differences in binge drinking among young adults through 2040.


Journal

Alcoholism, clinical and experimental research
ISSN: 1530-0277
Titre abrégé: Alcohol Clin Exp Res
Pays: England
ID NLM: 7707242

Informations de publication

Date de publication:
10 2021
Historique:
revised: 21 06 2021
received: 22 02 2021
accepted: 29 07 2021
pubmed: 7 11 2021
medline: 3 3 2022
entrez: 6 11 2021
Statut: ppublish

Résumé

Binge drinking among adolescents and young adults has changed over time, but patterns differ by age and gender. Identifying high-risk groups to target future efforts at reducing drinking in this population remains a public health priority. Forecasting methods can provide a better understanding of variation and determinants of future binge drinking prevalence. We implemented regression-based forecasting models to estimate the prevalence and gender differences in binge drinking among cohort groups of U.S. young adults, ages 18, 23-24, and 29-30 through 2040. Forecasting models were adjusted for covariates accounting for changes in demographic, Big-5 social roles (e.g., residential independence), and drinking norms and related substance use, to understand the drivers of forecasted binge drinking estimates. From the last observed cohort group (years varied by age) through 2040, unadjusted binge drinking prevalence was forecasted to decrease from 26% (95% CI: 20, 33%) (2011-15) to 11% (95% CI: 4, 27%) at age 18, decrease from 38% (95% CI: 30, 45%) (2006-2010) to 34% (95% CI: 18, 55%) at ages 23/24, and increase from 32% (95% CI: 25, 40%) (2001-2005) to 35% (95% CI: 16, 59%) at ages 29/30. Gender-stratified forecasts show a continuation in the narrowing of binge drinking prevalence between young men and women, though the magnitude of narrowing differs by age. Estimated trends were partially explained by changing norms regarding drinking and other substance use, though these indirect effects explained less of the total trend as age increased. Understanding how covariates influence binge drinking trends can guide public health policies to leverage the most important determinants of future binge drinking to reduce the harm caused by binge drinking from adolescence to adulthood.

Sections du résumé

BACKGROUND
Binge drinking among adolescents and young adults has changed over time, but patterns differ by age and gender. Identifying high-risk groups to target future efforts at reducing drinking in this population remains a public health priority. Forecasting methods can provide a better understanding of variation and determinants of future binge drinking prevalence.
METHODS
We implemented regression-based forecasting models to estimate the prevalence and gender differences in binge drinking among cohort groups of U.S. young adults, ages 18, 23-24, and 29-30 through 2040. Forecasting models were adjusted for covariates accounting for changes in demographic, Big-5 social roles (e.g., residential independence), and drinking norms and related substance use, to understand the drivers of forecasted binge drinking estimates.
RESULTS
From the last observed cohort group (years varied by age) through 2040, unadjusted binge drinking prevalence was forecasted to decrease from 26% (95% CI: 20, 33%) (2011-15) to 11% (95% CI: 4, 27%) at age 18, decrease from 38% (95% CI: 30, 45%) (2006-2010) to 34% (95% CI: 18, 55%) at ages 23/24, and increase from 32% (95% CI: 25, 40%) (2001-2005) to 35% (95% CI: 16, 59%) at ages 29/30. Gender-stratified forecasts show a continuation in the narrowing of binge drinking prevalence between young men and women, though the magnitude of narrowing differs by age. Estimated trends were partially explained by changing norms regarding drinking and other substance use, though these indirect effects explained less of the total trend as age increased.
CONCLUSIONS
Understanding how covariates influence binge drinking trends can guide public health policies to leverage the most important determinants of future binge drinking to reduce the harm caused by binge drinking from adolescence to adulthood.

Identifiants

pubmed: 34741556
doi: 10.1111/acer.14690
pmc: PMC9066164
mid: NIHMS1798127
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2069-2079

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA026861
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA001411
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016575
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01AA026861
Pays : United States

Informations de copyright

© 2021 by the Research Society on Alcoholism.

Références

Arch Gen Psychiatry. 2012 Dec;69(12):1304-13
pubmed: 22868751
JAMA. 2003 Jan 1;289(1):70-5
pubmed: 12503979
J Adolesc Health. 2020 Sep;67(3):354-361
pubmed: 32693983
J Clin Epidemiol. 2019 Jun;110:63-73
pubmed: 30878639
Lancet Public Health. 2020 May;5(5):e259
pubmed: 32277874
Nat Rev Cancer. 2006 Jan;6(1):63-74
pubmed: 16372017
J Appl Psychol. 1992 Aug;77(4):554-61
pubmed: 1387394
Arch Phys Med Rehabil. 2005 Jan;86(1):48-51
pubmed: 15640988
Dev Psychol. 2015 Jul;51(7):962-74
pubmed: 26010381
Drug Alcohol Depend. 2018 May 1;186:36-43
pubmed: 29544120
Arch Gen Psychiatry. 2009 Jul;66(7):785-95
pubmed: 19581570
Can J Public Health. 2008 May-Jun;99(3):172-7
pubmed: 18615935
J Epidemiol Community Health. 2017 Sep;71(9):912-918
pubmed: 28679538
Drug Alcohol Depend. 2007 Sep 6;90(1):72-80
pubmed: 17446013
Alcohol Clin Exp Res. 2015 Sep;39(9):1712-26
pubmed: 26331879
J Stud Alcohol. 2003 May;64(3):331-41
pubmed: 12817821
J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):692-702
pubmed: 19465879
J Epidemiol Community Health. 2017 Mar;71(3):308-312
pubmed: 27789756
Alcohol Clin Exp Res. 2019 Jul;43(7):1344-1359
pubmed: 31074877
BMC Public Health. 2016 Dec 8;16(1):1238
pubmed: 27931204
BMJ Open. 2016 Oct 24;6(10):e011827
pubmed: 27797998
Soc Psychiatry Psychiatr Epidemiol. 2017 Jan;52(1):117-126
pubmed: 27915406
PLoS One. 2014 Apr 08;9(4):e94130
pubmed: 24714027
Alcohol Clin Exp Res. 2019 Feb;43(2):287-298
pubmed: 30645773
Int J Gen Med. 2012;5:381-9
pubmed: 22615533
Br J Addict. 1985 Mar;80(1):83-99
pubmed: 3856453
Alcohol Clin Exp Res. 2017 Jul;41(7):1319-1328
pubmed: 28571107
JAMA Netw Open. 2020 Sep 1;3(9):e2022942
pubmed: 32990735
Int J Obes (Lond). 2013 Mar;37(3):448-54
pubmed: 22546778
Am J Public Health. 1993 Jun;83(6):872-80
pubmed: 8498627
J Stud Alcohol Drugs. 2012 Sep;73(5):772-82
pubmed: 22846241
Alcohol Res Health. 2000;24(4):225-32
pubmed: 15986717
Alcohol Clin Exp Res. 2016 Apr;40(4):816-25
pubmed: 27038595
Addiction. 2011 Nov;106(11):1925-32
pubmed: 21615581
J Cogn Dev. 2012;13(4):
pubmed: 24348099
Drug Alcohol Depend. 2005 Dec 12;80(3):377-86
pubmed: 16009507
Med J Aust. 2001 Mar 19;174(6):281-4
pubmed: 11297115
Australas Psychiatry. 2020 Oct;28(5):524-526
pubmed: 32722961
Addiction. 2005 Dec;100(12):1763-9
pubmed: 16367976
J Soc Clin Psychol. 2009 Sep;28(7):799-823
pubmed: 33767529

Auteurs

Jonathan M Platt (JM)

Columbia University, New York, New York, USA.

Justin Jager (J)

Arizona State University, Tempe, Arizona, USA.

Megan E Patrick (ME)

University of Michigan, Ann Arbor, Michigan, USA.

Deborah Kloska (D)

University of Michigan, Ann Arbor, Michigan, USA.

John Schulenberg (J)

University of Michigan, Ann Arbor, Michigan, USA.

Caroline Rutherford (C)

Columbia University, New York, New York, USA.

Katherine M Keyes (KM)

Columbia University, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH